The benefits of early ion channel screening

<p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">The latest sponsored DDW Sitting Down With podcast features</span> <span lang= "EN-US" xml:lang="EN-US">Dr Michael Morton, Director and Co-founder, ApconiX, and Dr Kimberly Rockley of ApconiX who discuss</span> <span lang="EN-US" xml:lang="EN-US">the benefits of early ion channel screening. The podcast covers</span> <span lang= "EN-US" xml:lang="EN-US">the hERG ion channel and its importance in cardiac safety screening in drug discovery.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Morton and Rockley outline</span> <span lang="EN-US" xml:lang="EN-US">the options available, the advantages of these approaches and how the results of hERG should and could be used to inform the drug discovery pathway.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Listen now.</span></p>